BS 001 and BS 006 oncolytic virus cocktail - Binhui Biopharmaceutical
Alternative Names: BS-001 and BS-006; oHSV2-CocktailLatest Information Update: 12 Jul 2022
At a glance
- Originator Binhui Biopharmaceutical
- Class Antineoplastics; Bispecific antibodies; Gene therapies; Oncolytic viruses
- Mechanism of Action Cell death stimulants; Immunologic cytotoxicity; Programmed cell death-1 ligand-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 20 Jun 2022 Preclinical trials in Solid tumours in China (Parenteral) (Wuhan Binhui Biotechnology pipeline, June 2022)